Publications

5532 Results

Intraperitoneal cislatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Authors
DS Alberts;PY Liu;EV Hannigan;R O'Toole;SD Williams;JA Young;EW Franklin;DL Clarke-Pearson;VK Malviya;B DuBeshter;MD Adelson;WJ Hoskins
Journal / Conference
New England Journal of Medicine 335(26):1950-1955
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8501 (INT-0051)

Prostate cancer prevention trial.

Authors
BH Zoltick
Journal / Conference
Presented at the AUAA Annual Assembly-Orlando Florida May 4-7 :
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Screening for prostate cancer: Opportunities for prevention.

Authors
IM Thompson;CA Coltman Jr
Journal / Conference
Seminars in Urologic Oncology 14(2)(Suppl.2):4-11
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Chemoprevention of prostate cancer with finasteride.

Authors
I Thompson;P Feigl;C Coltman
Journal / Conference
Principles and Practice of Oncology 10(3):1-18
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Southwest Oncology Group (SWOG)

Authors
LC Loll;CM Moinpour;P Feigl
Journal / Conference
Journal of the National Cancer Institute Monographs 20:83-85
Year
1996
Research Committee(s)
Cancer Control

A phase II trial of interferon-a and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.

Authors
L Elias;BA Blumenstein;J Kish;RC Flanigan;JL Wade;BA Lowe;JW Goodwin;ED Crawford
Journal / Conference
Cancer 78:1085-1088
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9122

Evaluation of topotecan in patients with recurrent or metastatic squamous cell carcinoma of the head and neck, a phase II Southwest Oncology Group study.

Authors
RE Smith;D Lew;GI Rodriguez;SA Taylor;JF Ensley
Journal / Conference
Investigational New Drugs 14:403-407
Year
1996
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9305 (CALGB-8984)

Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.

Authors
EA Poplin;J Jacobson;A Herskovic;TJ Panella;M Valdivieso;LF Hutchins;JS Macdonald
Journal / Conference
Cancer 78(9):1851-1856
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9060

Morphologic review of 2100 SWOG patients supports the REAL classification of lymphoma as clinically useful.

Authors
T Grogan;T Miller;S Dahlberg;R Braziel;P Banks;B Nathwani;C Kjeldsberg;R Tubbs;K Foucar;C Leith;C Spier;B Schnitzer;M Gulley;R Fisher
Journal / Conference
International Academy of Pathology Abstract-Book:112A(#650)
Year
1996
Research Committee(s)
Lymphoma

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 year of age and younger.

Authors
CM Balch;S Soong;AA Bartolucci;MM Urist;CP Karakousis;TJ Smith;WJ Temple;MI Ross;WR Jewell;MC Mihm Jr;RL Barnhill;HJ Wanebo
Journal / Conference
Annals of Surgery 224(3):255-266
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8393 (INT-0013)